Title: | Novel Process Platform for the Manufacturing and Purification of Biosimilar rHu Ranibizumab |
Area: | Medical Sciences |
Focus Area: | Biosimilar rHu Ranibizumab |
Social Benefits: | CSIR-NCL scientists have developed a novel process platform for the manufacturing purification of a biosimilar rHu Ranibizumab
, A novel cloning, expression refolding platform
Integrated continuous multimodal chromatography for purification
, A two-fold increase in productivity over the existing processes
, Biosimilarity has been demonstrated with Lucentis |
Developing Agency: | CSIR-National Chemical Laboratory (NCL), Maharashtra |
Technology Readiness Index: | Technology Development |
Email: | director@ncl.res.in |
| Website Link : | http://www.ncl-india.org |
| Source (more info) : | https://t.ly/l_sb |